Webinar recording online! Patient preferences for treatment of chronic pain
Bildtext
Osteoarthritis and Chronic Low Back Pain are two of the most common chronic pain conditions worldwide. To quantify patients’ perspectives on this unmet need, Pfizer and Lilly conducted a patient preference study in the US and UK. In this 10 March 2022 webinar, we describe the results of the study and the insights that contribute to the final PREFER recommendations.
The recorded webinar is now available on the PREFER YouTube channel. You can watch it in its entirety on YouTube or press play below. If you want to be invited to future PREFER webinars, sign up for our newsletter! Or have a look at our event calendar to find out what has been planned already.
Future PREFER events (Link removed)
Want to get specific? These are the presentations within the webinar!
- 00:00 Welcome & introduction
Lucy Abraham (Pfizer) - 04:30 Overview of study design & high-level results
Brett Hauber (RTI-HS) - 17:26 Methodological findings
Marco Boeri (RTI-HS) - 29:01 Quantitative benefit-risk evaluation
Kristin Bullok (Eli Lilly)